In vitro studies of dasatinib, its targets and predictors of sensitivity

Pigment Cell Melanoma Res. 2011 Apr;24(2):386-9. doi: 10.1111/j.1755-148X.2011.00835.x.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Clinical Trials as Topic
  • Dasatinib
  • Disease Progression
  • Drug Resistance, Neoplasm
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / enzymology*
  • Melanoma / pathology
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / enzymology
  • Skin Neoplasms / pathology
  • Thiazoles / therapeutic use*
  • src-Family Kinases / antagonists & inhibitors*
  • src-Family Kinases / metabolism

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • src-Family Kinases
  • Dasatinib